Trials / Completed
CompletedNCT00804271
Memantine and Validation of a New Alzheimer's Disease Scale
Open Label, Single-Arm, Multi-Centre, Study to Validate a New Alzheimer's Disease Scale in Patients With DAT, Treated With Memantine
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 487 (actual)
- Sponsor
- Merz Pharmaceuticals GmbH · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
To validate a new Alzheimer's Disease scale against other rating tools in subjects with dementia of Alzheimer's type, treated with memantine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | memantine | memantine tablets, OD, 12 weeks |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2009-11-01
- Completion
- 2009-11-01
- First posted
- 2008-12-08
- Last updated
- 2013-02-22
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00804271. Inclusion in this directory is not an endorsement.